Authors: Debrix, I Tilleul, P Milleron, B Grene, N Bouleuc, C Roux, D Liote, H Madelaine, I Bellanger, A Conort, O Fontan, JE Le Mercier, F Bardin, C Becker, A

Citation: I. Debrix et al., The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital, CLIN THER, 23(7), 2001, pp. 1116-1127

Authors: Grene, N Pointereau-Bellanger, A Conort, O Fontan, JE Le Mercier, F Madelaine, I Bardin, C Roux, D Debrix, I Tilleul, P

Citation: N. Grene et al., Multicenter study of the impact of prescription guidelines on the use of colony stimulating factors, ANTI-CANC D, 11(2), 2000, pp. 109-115

Authors: Beaussier, M Decorps, A Tilleul, P Balladur, P Lienhart, A

Citation: M. Beaussier et al., An observational evaluation of the rate of awakening after isoflurane or desflurane used in daily clinical practice, J CLIN ANES, 12(8), 2000, pp. 586-591

Authors: Debrix, I Madelaine, I Grenet, N Roux, D Bardin, C Le Mercier, F Fontan, JE Connor, O Pointereau, A Tilleul, P

Citation: I. Debrix et al., Impact of ASCO guidelines for the use of hematopoietic colony stimulating factors (CSFs): survey results of fifteen Paris university hospitals, PHARM WORLD, 21(6), 1999, pp. 270-271

Authors: Poujol, S Tilleul, P Astre, C Martel, P Fabbro, M Pinguet, F

Citation: S. Poujol et al., Effect of mitoxantrone liposomes on multidrug-resistant breast cancer cells, ANTICANC R, 19(4B), 1999, pp. 3327-3331